U.S. market Open. Closes in 1 hour 46 minutes

NBSE | NeuBase Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-12-312006-09-302005-12-312004-12-312003-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A389.00KN/A120.00K7.15M5.70M3.84M
Cost of Revenue1.26M575.52K280.46K128.37K13.90MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.20MN/AN/AN/A
Gross Profit-1.26M-575.52K-280.46K-128.37K-13.90MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.08MN/AN/AN/A
Operating Expenses33.32M26.57M17.07M26.34M9.08M23.85M25.31M17.47M9.12M4.62M3.29M1.24M1.02M932.88K640.00K-2.37MN/A3.76MN/AN/AN/A
Selling, General & Admin11.87M12.20M10.12M9.10M3.63M5.28M7.66M7.51M5.13M2.01M1.66M721.43K761.57K932.88K640.00K2.71M85.00K2.54M1.46M1.32M1.12M
Research & Development21.45M14.36M6.95M17.24M4.32M17.41M16.46M8.78M3.99M2.61M1.63M521.97K254.02KN/AN/AN/AN/A1.22MN/AN/AN/A
Other Operating Expenses-166.87K450.31K412.37K12.97M592.58K1.17M1.19M1.18MN/AN/AN/AN/AN/AN/AN/A-5.08MN/AN/AN/AN/AN/A
Operating Income-33.32M-26.57M-17.07M-26.34M-13.90M-23.78M-25.31M-17.47M-9.12M-4.62M-3.29M-1.24M-1.02M-932.88K-640.00K2.76MN/A-4.84M12.71M9.62M6.44M
Other Expenses / Income-458.11K1.16M-315.21K-621.84K-4.23M-30.92K-459.88K2.27M-7.74K-1.03M1.83M-3.86M1.51M68.43K11.00K-1.62MN/A100.00K-12.58M-9.16M-6.33M
Before Tax Income-33.78M-25.41M-17.38M-26.96M-13.24M-23.81M-25.77M-15.20M-9.13M-5.65M-1.45M-5.10M494.38K-864.45K-629.00KN/A-85.00K-4.74M128.00K454.67K106.61K
Income Tax Expenses458.11K258.11K-123.27K128.95K8.98MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-24.69KN/A52.14K169.64K4.75K
Net Income-34.23M-25.67M-17.26M-27.09M-13.24M-23.81M-25.77M-15.20M-9.13M-5.65M-1.45M-5.10M494.38K-864.45K25.00K-6.30M63.74K-4.74M75.86K285.03K101.85K
Interest Expenses24.05K32.33K7.69K128.95K-667.05KN/AN/A5.98K5.58K4.69K1.82K2.43K21.49K25.80KN/AN/AN/A100.00K4.01K3.68K14.02K
Basic Shares Outstanding1.62M1.37M981.01K413.58K141.46K2.24M1.57M1.42M1.11M935.39K712.14K644.45K547.03K420.78K420.78K237.58K34.66K30.00K49.08K48.90K47.92K
Diluted Shares Outstanding1.62M1.37M981.01K413.58K141.46K2.24M1.57M1.42M1.11M935.39K712.14K644.45K547.03K420.78K638.72K237.58K34.66K30.00K49.08K48.90K47.92K
EBITDA-32.49M-25.92M-16.92M-26.21M-3.13M-22.69M-24.12M-16.29M-8.66M-4.53M-3.20M-1.16M-995.15K-932.88K-651.00K-6.14MN/A-4.38M193.50K508.21K168.81K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,578.66%0.00%-3,650.00%2.71%8.92%4.39%
EBIT-33.75M-25.38M-17.38M-26.83M-4.92M-23.81M-25.77M-15.19M-9.13M-5.65M-1.45M-5.10M515.87K-838.65K25.00K-6.30M39.05K-4.64M132.01K458.35K120.62K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,620.57%0.00%-3,866.67%1.85%8.04%3.14%
Financial Year End2022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-12-312006-09-302005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙